Indonesia Selected as Testing Country for 100-Day Vaccine Target to Anticipate Pandemics
Indonesia has officially been selected as one of three countries in the world to pilot the 100-day vaccine development target. This program, known as the '100 Days Mission,' is a global initiative aimed at accelerating the vaccine manufacturing process in the event of new pandemic threats in the future.
This step is taken as a global effort to anticipate the risk of emerging dangerous infectious diseases. By significantly shortening vaccine development time, it is hoped that the global health response can be carried out more quickly and effectively to save many lives.
As a testing country, Indonesia will be involved in various measurable stages of research and development. This participation not only strengthens Indonesia's position on the global health map but also provides early access for national medical personnel and researchers to understand the latest vaccine technology.
Furthermore, Indonesia's involvement in this mission is expected to increase national self-reliance in vaccine production. The government hopes that the experience gained from this program will strengthen the domestic health resilience system to be better prepared for future health challenges.
Overall, this initiative serves as a strategic step for Indonesia to contribute to global health security. With the support of technology and international collaboration, Indonesia is committed to ensuring that vaccine development can be carried out efficiently and safely for the entire community.